Thomson Reuters Finds Increase in New Research for 'Neglected' Tropical Diseases

Article

The Intellectual Property & Science division of Thomson Reuters announces the publication of a new study tracking the current status of research on neglected tropical diseases. The Global Research Report Neglected Tropical Diseases analyzes research output across countries and fields from 1992-2011 and finds a two-fold increase in published literature focused on a group of diseases identified by the World Health Organization as underserved by public health services.  Despite these recent gains, the total research output is still significantly less than that of first world diseases.
                                                                                           
Though the analysis finds that research output focused on neglected tropical diseases has doubled from roughly 2,500 papers in 1992 to well over 5,000 papers in 2011, these totals still pale in comparison to other diseases such as cancer (85,000 papers), HIV/AIDS (16,000 papers) and coronary artery disease (15,000 papers).  To put this in context, more than 1 billion people are infected with one or more neglected tropical diseases and more than half a million die each year from their infections, compared with about 35 million globally who are infected with HIV or the about 346 million afflicted with diabetes. 

Amidst high profile debate over the effectiveness of global health initiatives such as U.S. President Obamas Emergency Plan for AIDS Relief (PEPFAR), it is important for policymakers to understand the full scope of current research into diseases that affect a disproportionate amount of the worlds population, says Jonathan Adams, director of research and development for Thomson Reuters.  Neglected tropical diseases affect more than one billion people around the world; we can only truly begin to direct solutions to this problem once we understand the current research landscape and start to develop programs that address gaps in it.

In addition to the aggregate bibliographic analysis, the Thomson Reuters research also reviewed research output by region and individual disease and suggests strategies for fostering increased neglected tropical disease research.  Following were the key findings:

 Brazil and India Show Steepest Growth in New Research: Though most research papers addressing neglected tropical diseases carry an author from one of the economies in the G7, Brazil and India have a surprisingly strong presence in the research arena.  The nations publishing most often in neglected tropical disease research are the US, UK, Brazil and India.

 Dengue Research Shows Sharpest Rise Over Last 10 Years: The specific diseases cited most frequently in published research over the last 20 years are Soil Transmitted Helminthiasis, Schistosomiasis and Lymphatic Filariasis.  Dengue research has shown the sharpest recent growth, nearly tripling in output between 2002 and 2011.

 Research Shows Evolution Toward Prevention and Treatment: Research into neglected tropical diseases has shown a notable spread across journal categories from core biomedical areas to fields relating to the ecology of the disease and the social and health environment in which these diseases are prevalent.  This signals a shift towards solutions that move from studying the disease to creating remedies.

Data for this report was drawn from Web of Science database, available on the Thomson Reuters Web of Knowledge platform. The database covers more than 100 years of research in more than 12,000 of the highest impact journals, and more than  150,000 conference proceedings records from around the world.

View the Global Research Report Neglected Tropical Diseases HERE.

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content